Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04029311
Other study ID # 20170991
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 8, 2017
Est. completion date May 7, 2019

Study information

Verified date March 2021
Source Adame, J. Michael, D.D.S.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study the effects of two combination therapies for patients with obstructive sleep apnea (OSA) who have been both intolerant to Positive Airway Pressure (PAP) therapy and sub-therapeutic to oral appliance therapy. Hypothesis 1. There is a difference between Continuous Positive Airway Pressure (CPAP) vs CPAP/Oral Appliance (OA) connect vs CPAP/OA disconnected in terms of: 1. Apnea Hypopnea Index (AHI) reduction 2. Amount of side effects 3. Amount of Leaks 4. Hours of use (compliance) 5. CPAP pressure 2. There is a difference between connected and disconnected for the following symptoms: 1. Epworth sleepiness Scale (ESS) 2. Functional Outcomes of Sleep Questionnaire (FOSQ) 3. Side effects Study Design - randomized prospective parallel


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date May 7, 2019
Est. primary completion date February 6, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Baseline diagnosis AHI > or = 5 plus ESS . or = 10. - PAP Intolerance - Partial Response to oral appliance therapy: AHI > 5 - Age: > 18 Exclusion Criteria: History of daily use of alcohol, narcotics or Central Nervous System (CNS) depressants. - Diagnosis of Central Sleep Apnea - Pregnancy - Edentulous - Prisoners

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nuance Pro
Study compares Nuance Pro plus Automatic Positive Airway Pressure (autoPAP) vs TAP PAP plus autoPAP
autoPAP
autoPAP
TAP PAP
TAP PAP

Locations

Country Name City State
United States J. Michael Adame, DDS, PA Edinburg Texas

Sponsors (1)

Lead Sponsor Collaborator
Joseph Adame

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Apnea-Hypopnea Index Episodes per hour that the patient experiences apneas and/or hypopneas 2 months
Primary PAP Pressure The pressure required to treat the patient successfully 2 months
Primary Leaks The Liters/Minute of leaking of the PAP machine 2 months
Primary Hours of Use The average hours of use per night of each of the combination therapies 2 months
Primary Epworth Sleepiness Scale (ESS) The ESS is a self-administered questionnaire with 8 questions. The score can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life. 2 months
Primary Functional Outcomes Sleep Questionnaire (FOSQ) FOSQ is a disease specific quality of life questionnaire to determine how sleepiness interferes one's quality of life. The total score range from 5 to 20 (10 questions, 1-4 points per each). The lower values represent a worse quality of life. 2 months
Primary Intolerance Questionnaire This questionnaire consists of 4 questions to determine the frequency of 4 typical side-effects from positive airway pressure therapy. The score ranges from 0 to 16 (4 questions, 0-4 points per each). The higher value represent worse side effects. 2 months